Can Insight Health turn voice-first clinical agents into a durable healthcare infrastructure layer?
Insight Health raised $11m to expand healthcare admin AI. Read what this funding means for scaling, adoption, and clinical workflow change.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Premier Radiology Services deepens outpatient teleradiology push with Global Imaging Solutions
Premier Radiology Services has acquired Global Imaging Solutions. Read what the teleradiology deal changes for outpatient imaging and market competition.
Medical Devices & Diagnostics
How electroCore, Inc. is strengthening the clinical case for bioelectronic medicine in trauma-related brain injury
electroCore, Inc.’s latest data could reshape bioelectronic medicine in trauma-related brain injury. Read what clinicians and industry watchers may track next.
Medical Devices & Diagnostics
Corcept Therapeutics expands hypercortisolism evidence base with largest US resistant hypertension screening trial
Corcept's MOMENTUM trial finds hypercortisolism in 27.3% of resistant hypertension patients. Explore what this means for screening and treatment. Read more.
Medical Devices & Diagnostics
What Anumana’s FDA-cleared pulmonary hypertension algorithm means for cardiovascular AI
Anumana won FDA clearance for an ECG-AI pulmonary hypertension tool. Read what it changes for diagnosis, workflow adoption, and cardiovascular AI strategy.
Medical Devices & Diagnostics
Medtronic broadens Stealth AXiS reach as integrated surgical platforms gain strategic importance
Medtronic won FDA clearance for Stealth AXiS in cranial and ENT surgery. Read why this platform move could reshape surgical workflow competition.
Medical Devices & Diagnostics
LensOne enters pivotal study as Long Bridge Medical targets a difficult gap in secondary IOL fixation
Long Bridge Medical’s LensOne has entered a pivotal FDA-cleared study. Read why this ophthalmic device trial could reshape secondary IOL fixation.
Medical Devices & Diagnostics
Can smaller eyedrops improve glaucoma outcomes? Nanodropper data make the case
Nanodropper’s glaucoma study suggests microdrops may improve pressure control and reduce waste. Read what this could mean for eye care.
Medical Devices & Diagnostics
What Invivoscribe’s IdentiClone Dx IGH approval reveals about the new economics of IVDR-ready hematology diagnostics
Invivoscribe’s IdentiClone Dx IGH won IVDR certification in the EU. Read what this means for clonality testing, lab adoption, and diagnostic competition.
Medical Devices & Diagnostics
Imperative Care begins CLEAR-IT study as peripheral thrombectomy moves from device adoption to evidence scrutiny
Imperative Care’s CLEAR-IT study could reshape peripheral thrombectomy standards. Read why its real-world data strategy matters now.